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Abstract 
Objective: To examine the effect of the diagnosis of asymptomatic disease on health-related 
quality of life (HRQoL).  
Design: Secondary analysis of a national dataset. 
Method: We analyzed adult participants in the 2011-2012 National Health and Nutrition 
Examination Survey (NHANES) of the civilian non-institutionalized United States general 
population. Across three asymptomatic diseases (glucose intolerance, hyperlipidemia, 
hypertension), we examined four groups (without disease; with disease but no diagnosis; with 
disease and diagnosis but no treatment; with disease, diagnosis, and treatment). For each 
asymptomatic disease, we examined group differences in self-rated health (ordinal logistic 
regression) and Healthy Day outcomes (number of the last 30 days that physical health was not 
good, mental health was not good, or inactive; regression). Models were adjusted for age, sex, 
smoking status, insurance status, income, education, race, body mass index, and comorbid 
conditions.  
Results: Analyses included 6012 respondents (glucose intolerance), 2772 respondents 
(hyperlipidemia), and 5524 respondents (hypertension). In adjusted models, those who did not 
know about their disease had the same self-rated health scores as those without the disease, those 
with the disease without treatment, and those with disease and treatment. In adjusted analyses of 
the Healthy Days questions, those with unknown disease reported the same number of unhealthy 
days as those without disease with the exception of glucose intolerance.  Conversely, in four of 
the nine possible comparisons, those with known disease without treatment reported more 
unhealthy days that those with who did not know about their disease. 
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Conclusions: In adjusted analyses, individuals knowing about their asymptomatic disease are 
more likely to experience decrements in healthy days compared to those without knowledge of 
their asymptomatic disease. 
Keywords: HRQoL, diagnosis, glucose intolerance, hyperlipidemia, hypertension. 
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Introduction 
Asymptomatic disease is common among adults in the United States, as there are an 
estimated 71 million with hyperlipidemia, 67 million with hypertension, 29 million with 
diabetes, and 86 million with pre-diabetes (Centers for Disease Control and Prevention [CDC], 
2014; CDC, 2015a; CDC, 2015b).  Screening for these diseases is part of routine health care 
because early detection and treatment of these diseases reduces morbidity and mortality later in 
life. For example, early detection and treatment of hypertension reduces future risk of stroke.  
There are a wide variety of considerations taken into account with the initiation of screening 
programs for asymptomatic diseases, including economic costs of screening, treatment options, 
and benefits of early treatment (Harris et al., 2001). 
While early treatment of these diseases can reduce the risk of negative health outcomes 
later in life, being labeled with a disease and undergoing medical interventions can introduce the 
risk of adverse physical, mood, and cognitive effects.  Medication side effects are common for 
many of the leading treatments for asymptomatic illness (Bailey & Turner, 1996; Armitage, 
2007; Kaplan, 1992). For individuals who experience adverse effects from medication, treatment 
of an asymptomatic illness could, ironically, result in lower health-related quality of life 
(HRQoL) compared to individuals who do not receive treatment until a substantial sequela (e.g., 
stroke or vision loss) occurs. Empirical evidence from research on the psychology of illness 
supports the notion that awareness of a diagnosis may reduce general health perceptions by 
change in illness identity (Hagger & Orbell, 2003) or perception of symptoms (Petersen, van den 
Berg, Janssens, & Van den Bergh, 2011). In a classic health psychology experiment conducted 
by Baumann and colleagues (1989), participants were randomly assigned to receive bogus 
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diagnostic feedback that their blood pressure was high. These participants were more likely to 
report experiencing physical symptoms associated with high blood pressure than the group who 
received diagnostic feedback that their blood pressure was normal. Additionally, being labeled 
with an illness has potential cognitive consequences, such as increased worry or rumination 
(Hagger & Orbell, 2003), and introduces the societal judgment of illness stigma (Martinez & 
Hinshaw, 2016; Quinn & Earnshaw, 2011). Among individuals living with chronic illness, 
anticipated illness stigma is associated with lower in quality of life via increases in stress 
(Earnshaw, Quinn, & Park, 2011). Experimental research has demonstrated physiological 
changes of stigma activation. Among a sample of 122 veterans living with hypertension, using a 
subtle manipulation to activate their hypertensive label associated with acute increases in anxiety 
and acute increases in blood pressure among older individuals who were invested in living 
independently (Auman, Bosworth, & Hess, 2005).   
There has been sparse evaluation of the association between diagnosis of asymptomatic 
diseases and HRQoL in population studies. Previous studies comparing individuals who do and 
do not know their diagnosis have included patients receiving treatment in the group aware of 
their diagnosis, which impedes the ability to isolate the effects of diagnosis from the effects of 
treatment (Edelman, Olsen, Dudley, Harris, & Oddone, 2002; Erickson, Williams, & Gruppen, 
2001; Jørgensen, Langhammer, Krokstad, & Forsmo, 2014; Lawrence, Fryback, Martin, Klein, 
& Klein, 1996). The most commonly used large dataset for such analyses has been the National 
Health and Nutrition Examination Survey (NHANES), which combines diagnostic and survey 
information. Previous NHANES studies focused on a single condition (i.e., hypertension) have 
found that the diagnosis of hypertension was associated with lower self-rated health than the 
treatment of hypertension (Hayes, Denny, Keenan, Croft, & Greenlund, 2008; Barger & 
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Muldoon, 2006). In this report, we expand upon prior work to examine three asymptomatic 
diseases which were detected during the physical and laboratory examination of the 2011-2012 
NHANES survey: hypertension, as in previous reports, as well as the first examination of 
glucose intolerance and hyperlipidemia. Using a combination of objective information and 
participants’ self-reports we categorized individuals into four groups: those living with (1) no 
disease; (2) undiagnosed asymptomatic disease; (3) diagnosed, untreated asymptomatic disease; 
and (4) diagnosed, treated asymptomatic disease. We included all four groups to allow for 
detailed comparisons, but specifically hypothesized that individuals in group 3 would report 
lower HRQoL than individuals in group 2. That is, we predict that individuals who are aware of 
their asymptotic disease (and are not receiving treatment) would report lower HRQoL than 
individuals who are living with asymptomatic disease, and are unaware of it.  
Method 
Participant Dataset 
We used publicly available data from the 2011-2012 NHANES (CDC, 2010). NHANES 
samples civilian, non-institutionalized residents of the United States. It is a continuous annual 
survey with a complex, stratified, multistage probability sample design. All persons are 
interviewed in their home and asked to have a health examination at a mobile examination 
center. We used all respondents age 18 and older in the 2011-2012 NHANES with examination 
data as this was the last year that the healthy days outcomes were collected. The unweighted 
response rate in 2011-2012 was 67.3% for the adult interviewed sample and 64.5% for the adult 
examined sample. 
Measures 
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 Asymptomatic disease classifications. Three diseases captured by NHANES fulfilled 
the following criteria: (1) the disease is generally asymptomatic, (2) the disease can be diagnosed 
using physiological measurements from NHANES, (3) participants are directly asked if they 
have been diagnosed with the disease, and (4) participants are directly asked if they are currently 
being treated for the disease with medications. The three diseases that met these criteria were 
hyperlipidemia, diagnosed by low-density lipoprotein higher than 190 mg/dL in a fasting 
venipuncture sample (Report of the National Cholesterol Education Program, 2001); glucose 
intolerance/diabetes mellitus (hereafter referred to as “glucose intolerance”), diagnosed by 
hemoglobin A1C  greater than 5.6 mmol/L from any venipuncture sample (American Diabetes 
Association, 2010); and hypertension, diagnosed by average of three blood pressure 
measurements with average systolic blood pressure greater than 140 mmHg or average diastolic 
blood pressure greater than 90 mmHg (Chobanian et al., 2003). We excluded individuals from 
the glucose intolerance group with a hemoglobin A1C greater than 10, given that these levels of 
glucose can result in physical symptoms.  
Diagnostic groups. Using the asymptomatic disease classifications, we created the 
following four groups of respondents for each disease (1) No Disease referred to those who 
reported not being diagnosed with the disease and did not meet criteria for diagnosis, (2) 
Unknown Disease referred to those who reported not being diagnosed with the condition and met 
the criteria for diagnosis, (3) Known Disease without Treatment indicated those who reported 
being diagnosed with the disease but not prescribed medications for it, and (4) Known Disease 
with Treatment was assigned to those who reported being diagnosed with the condition and 
prescribed medications for it. 
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Health related Quality of Life outcomes. HRQoL is a complex, multi-dimensional 
concept (Wilson & Cleary, 1995) which has been quantified in several ways.  For this analysis, 
we use the standard measures of HRQoL as measured by the Center for Disease Control for 
population health measurement; self-rated health and the Heathy Days Measures 
(https://www.cdc.gov/hrqol/methods.htm).  Self-rated health is one of the most basic and 
fundamental HRQoL measures. It is a well-studied outcome and is predictive of a wide range of 
other outcomes, including mortality and medical expenditures (DeSalvo, Bloser, Reynolds, He, 
& Muntner, 2006; DeSalvo et al, 2009). The Healthy Days questions ask how many days in the 
last 30 physical health was not good, mental health was not good, and poor health kept someone 
from their usual activities.  
Self-rated health. The primary outcome of interest was response to the statement, “In 
general, my health is: excellent, very good, good, fair, poor.”   
Healthy days. Participants responded to three items regarding their functioning over the 
previous 30 days: (1) the number of days physical health was not good in the last 30 days, (2) the 
number of days mental health was not good in the last 30 days, and (3) the number of inactive 
days due to physical or mental health.  
Demographic and health history variables. Adjusted models included other personal 
factors that could influence HRQoL: age in years; sex; smoking status (yes/no); insurance status 
(yes/no); income (0-$19 999; $20 000-$44 999; $45 000-$99 999; and $100 000 or more); 
education (less than high school, high school graduated/GED or equivalent, some college or 
associates degree, and college graduate or above); race/ethnicity (Non-Hispanic White, Mexican 
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American, Other Hispanic, Non-Hispanic Black, Non-Hispanic Asian, Other); and body mass 
index (BMI). Additionally, other chronic health conditions were included as an additional control 
variable. Chronic health conditions were operationalized as a sum of the self-reported presence 
of the following health conditions: angina, arthritis, asthma, cancer, chronic bronchitis, 
emphysema, heart attack, heart disease, heart failure, liver condition, psoriasis, stroke, and 
thyroid problem. The number of comorbid chronic conditions was analyzed as 0, 1, 2, or 3 or 
more. 
Analyses 
Self-rated health was analyzed using ordinal logistic regression models. The three health 
conditions were analyzed separately using diagnostic group while adjusted for demographic and 
other chronic health conditions.  Self-rated health was coded such that the results are the odds of 
reporting worse self-rated health; odds above 1.0 represent worse self-rated health. Healthy days 
measures were analyzed using multivariate regression. The three health conditions were analyzed 
separately using diagnostic group while adjusted for demographic and medical variables. In these 
models, parameter estimates represent number of unhealthy days; positive numbers represent 
worse health. All regression analyses included the weights, strata, and clusters provided in 
NHANES so that results are representative of the USA.  Analyses were performed with SAS 9.4 
(PROC FREQ, PROC SURVEYLOGISTIC, and PROC SURVEYREG). 
  The funding organizations had no role in the design and conduct of the study; in the 
collection, analysis, and interpretation of the data; or in the preparation, review, or approval of 
the manuscript. These analyses did not require IRB approval as they are a secondary analysis of 
publicly available, deidentified data. 
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Results 
The number of respondents analyzed for each disease was 6104 for glucose intolerance, 
2773 for hyperlipidemia, and 5524 for hypertension (Table 1). Ninety-eight percent of 
respondents with hyperlipidemia had been diagnosed by a health care provider, 85% of 
respondents with hypertension, and only 40% of respondents with glucose intolerance, consistent 
with prior reports (Bowen, Xuan, Halm, 2014). Demographic information by disease and 
diagnosis category is in the Appendix. Respondents without the diseases tended to be younger, 
non-smokers, have lower BMI, and less comorbidity than respondents with the diseases.   
Self-rated Health  
Unadjusted response frequencies for all four diagnostic groups (No Disease, Unknown 
Disease, Known Disease without Treatment, and Known Disease with Treatment) for each 
condition (glucose intolerance, hyperlipidemia, and hypertension) for the primary outcome are 
presented in Figure 1. For all three conditions, the proportion of respondents who reported 
“excellent” or “very good” health decreased across the four diagnostic groups from No Disease, 
to Unknown Disease, to Known Disease without Treatment, to Known Disease with Treatment. 
The proportion of those in “good” health was similar across the diagnostic groups. The 
proportion of those in “fair” or “poor” health increased from No Disease, to Unknown Disease, 
to Known Disease without Treatment, to Known Disease with Treatment groups. 
Adjusted odds ratios for reporting worse self-rated health in each health condition are 
presented in Table 2.   Compared to the Unknown Disease reference group, there were no 
statistically significant differences in self-rated health by diagnostic category.  There were 
several other factors that were statistically significant predictors of self-rated health which are 
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available in the Appendix. The odds of reporting worse self-rated health increased with female 
sex, lower income, and lower education, any race/ethnicity that was not non-Hispanic White, 
being a smoker, and increasing number of comorbidities.   
Healthy Days 
Unadjusted healthy days question responses for each condition and diagnostic group are 
reported in Table 3. In general, the Unknown Disease group reported the fewest number of poor 
health or inactive days. The Known Disease without Treatment and Known Disease with 
Treatment groups reported having poorer health and more inactive days than the No Disease and 
Unknown Disease groups. 
The estimates from the adjusted model for the healthy days questions are reported in 
Table 4 with full model results in the Appendix.  Compared to the Unknown Disease reference 
group, those without disease did not have statistically significantly different numbers of healthy 
days except that those without glucose intolerance reported 0.79 less physically unhealthy days 
(p=0.010) than those with Unknown glucose intolerance.  In contrast, four of the nine 
comparisons (three diseases with three healthy days questions each) of Known Disease without 
Treatment to the Unknown Disease reference had statistically significantly larger numbers of 
unhealthy days (range 1.4 to 2.5 more unhealthy days).  Three of these are in hypertension and 
one is in glucose intolerance (inactive days).  These statistically significant differences remained 
for the same questions and diseases except mental health days in hypertension when comparing 
Known Disease with Treatment to Unknown disease with a smaller magnitude (range 0.9 to 1.1 
more unhealthy days). 
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In addition to diagnostic group, more days in poor health and more inactive days were 
generally associated with female sex, younger age, lower income, increasing numbers of 
comorbid conditions, and being a smoker. 
Discussion 
 We analyzed a nationally representative sample of the United States adult population and 
found that diagnosis of glucose intolerance or hypertension, even without potential treatment 
side effects, negatively associated with healthy days when compared to individuals who have 
these diseases but do not know about them. The diagnosis of these diseases was associated with 
more days that physical and mental health was not good (hypertension) and more days of 
inactivity due to poor physical or mental health (hypertension and glucose intolerance). These 
findings support the idea that the diagnosis of asymptomatic disease affects general health 
perceptions and HRQoL. While the direction of the effects were the same in the hyperlipidemia 
cohort, their differences were not statistically significant. This may be due to the smaller sample 
size of the undiagnosed hyperlipidemia group compared to the other two diagnostic groups. 
We selected diseases believed to be asymptomatic in the early stages to test our 
hypothesis that the undiagnosed group would have the same HRQoL as those without the health 
condition, and that the diagnosis itself would negatively impact HRQoL. Consistent with our 
assumptions, most models did not show any difference between the No Disease and the 
Unknown Disease groups. The exception was for glucose intolerance, in which those who were 
in the No Disease group  had fewer days when physical health was not good (-0.79; P = 0.010) 
when compared to those without the condition. This may be because those with glucose 
intolerance may have some symptoms (e.g., polydipsia, fatigue), or that we did not have access 
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to covariates to adequately adjust for diabetes risk factors, which are also associated with lower 
HRQoL (e.g., physical activity).  
Taken together, these findings suggest that there is an effect of diagnosing an 
asymptomatic disease which influences an individual’s general health perceptions and reported 
HRQoL. This effect of labelling a disease in an individual could have several mechanisms which 
include changes in an individual’s identity (e.g., illness identity) and the way an individual 
interprets symptoms. While the majority of research on illness representations and identity of 
illness focuses on how individuals evaluate their HRQoL and how they label particular 
symptoms (Hagger & Orbell, 2003; Leventhal, Leventhal, & Contrada, 1998), the current 
findings encourage further research to explore how an individual’s illness identity and symptom 
experience are impacted by receiving a diagnosis. Investigating a causal pathway and potential 
mediators (e.g., general health perceptions, cognitive or affective experiences of symptoms) after 
receiving an asymptomatic diagnosis could reveal a potential mediator connecting diagnoses to 
overall HRQoL.  
Further characterization of the pathways from diagnosis to change in HRQoL may 
provide insights which could be used to support patients diagnosed with these diseases. There are 
many possible mediators of this pathway, such as emotive and cognitive mediators (e.g., anger, 
fear, worry, anxiety); attentional focus to symptomology, which is confirmed by symptom-
seeking biases; or identifying as a member of an ill or stigmatized community. The unforeseen 
consequences of changing general health perceptions could include changes in medication 
adherence, interactions with medical community, reductions in self-efficacy for health promoting 
behaviors (e.g., I can’t exercise because I am hypertensive), or increased engagement in negative 
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coping patterns (e.g., stress eating, substance use). Characterizing and intervening on these 
pathways would allow patients to maximize their current HRQoL and may improve a variety of 
long-term outcomes. 
Several limitations of this study merit comment. First, the data are cross-sectional, and 
there are a variety of potential confounders which were not available in the dataset (e.g., 
treatment side effects). Second, the diseases explored in this study do have long-term sequela, 
which may be present in the Unknown Disease groups. If present, this would dampen the 
difference of the effect of diagnosis between the Unknown Disease and Known Disease (with or 
without treatment) groups and bias toward not finding a difference. Lastly, the Unknown Disease 
group may not be diagnosed because they do not receive regular health care, which itself may be 
an indicator of personal, social, or structural mediators of HRQoL and health. 
Screening and diagnosing asymptomatic disease has myriad benefits including avoiding 
and delaying sequela, such as stroke, vision loss, heart attack, kidney failure, and neuropathy. 
While we have found evidence that HRQoL is diminished by the diagnosis and subsequent 
treatment of asymptomatic diseases, we are not advocating to change screening guidelines as 
there is substantial benefit to early detection and treatment (Sullivan, Lawrence, & Ghushchyan, 
2005).  While self-rated health is related to mortality (DeSalvo, Bloser, Reynolds, He, & 
Muntner, 2006), this relationship is not known to be causal, and it would be inappropriate to 
assume that diagnosis of asymptomatic disease increases mortality.   
Our study’s findings are strengthened by exploring multiple health conditions, separating 
the effects of diagnosis from the effects of treatment, and controlling for a wide variety of factors 
influencing HRQoL. This research is the first to examine whether the diagnosis of three different 
 15 
 
asymptomatic diseases is associated with decrement in HRQoL in a nationally representative 
sample from the United States. Our findings suggest that diagnosing an asymptomatic condition 
negatively impacts an individual’s HRQoL. Clinicians should be cognizant of the potential for 
decreases in HRQoL in those diagnosed with a health condition, even when no treatment is 
required. Future work should elicit the mediators of this relationship to guide interventions for 
patients and clinicians. 
Acknowledgements 
We gratefully acknowledge the individuals who participated in, and conducted, the 
National Health and Examination Survey; without their contributions, this work would not be 
possible.  
  
 16 
 
References 
American Diabetes Association. (2010). Standards of medical care in diabetes—2010. Diabetes 
care, 33(Supplement 1), S11-S61. https://doi.org/10.2337/dc10-S011 
Armitage, J. (2007). The safety of statins in clinical practice. The Lancet,370(9601), 1781-1790. 
https://doi.org/10.1016/S0140-6736(07)60716-8 
Auman, C., Bosworth, H. B., & Hess, T. M. (2005). Effect of health-related stereotypes on 
physiological responses of hypertensive middle-aged and older men. The Journals of 
Gerontology Series B: Psychological Sciences and Social Sciences, 60(1), P3-P10. 
Bailey, C. J., & Turner, R. C. (1996). Metformin. The New England Journal of Medicine, 334(9), 
574. https://doi.org/10.1056/NEJM199602293340906 
Barger, S. D., & Muldoon, M. F. (2006). Hypertension labelling was associated with poorer self-
rated health in the Third US National Health and Nutrition Examination Survey. Journal 
of Human Hypertension, 20(2), 117-123. https://dx.doi.org/10.1007%2Fs00467-015-
3262-8 
Baumann, L. J., Cameron, L. D., Zimmerman, R. S., & Leventhal, H. (1989). Illness 
representations and matching labels with symptoms. Health Psychology,8(4), 449. 
http://psycnet.apa.org/doi/10.1037/0278-6133.8.4.449 
Bowen, M.E., Xuan, L, Halm E. (2014) The hunt for diabetes: Characteristics and risk factors 
associated with undiagnosed diabetes and prediabetes in NHANES. Journal of General 
Internal Medicine 29(S1) 226-226. https://dx.doi.org/10.1007%2Fs11606-014-2834-9 
 17 
 
Centers for Disease Control and Prevention (CDC). National Center for Health Statistics  
(NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. 
Department of Health and Human Services, Centers for Disease Control and Prevention, 
2010-2011, http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm. Accessed June 
18, 2015. 
Centers for Disease Control and Prevention. Diabetes Latest. June 17, 2014. 
http://www.cdc.gov/features/diabetesfactsheet/. Accessed June 18, 2015. 
Centers for Disease Control and Prevention. Cholesterol Facts.  March 17, 2015. 
http://www.cdc.gov/cholesterol/facts.htm. Accessed June 18, 2015. 
Centers for Disease Control and Prevention. High Blood Pressure Facts. February 19, 2015. 
http://www.cdc.gov/bloodpressure/facts.htm. Accessed June 18, 2015. 
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo Jr, J. L., ... & 
National High Blood Pressure Education Program Coordinating Committee. (2003). The 
seventh report of the joint national committee on prevention, detection, evaluation, and 
treatment of high blood pressure: the JNC 7 report. Jama, 289(19), 2560-2571. 
https://doi.org/10.1001/jama.289.19.2560 
DeSalvo, K. B., Bloser, N., Reynolds, K., He, J., & Muntner, P. (2006). Mortality prediction 
with a single general self‐rated health question. Journal of General Internal 
Medicine, 21(3), 267-275. https://dx.doi.org/10.1111%2Fj.1525-1497.2005.00291.x 
DeSalvo, K. B., Jones, T. M., Peabody, J., McDonald, J., Fihn, S., Fan, V., ... & Muntner, P. 
(2009). Health care expenditure prediction with a single item, self-rated health 
 18 
 
measure. Medical Care, 47(4), 440-447. 
https://doi.org/10.1097/MLR.0b013e318190b716 
Earnshaw, V. A., Quinn, D. M., & Park, C. L. (2012). Anticipated stigma and quality of life 
among people living with chronic illnesses. Chronic Illness, 8(2), 79-88. 
Edelman, D., Olsen, M. K., Dudley, T. K., Harris, A. C., & Oddone, E. Z. (2002). Impact of 
diabetes screening on quality of life. Diabetes Care, 25(6), 1022-1026. 
https://doi.org/10.2337/diacare.25.6.1022 
Erickson, S. R., Williams, B. C., & Gruppen, L. D. (2001). Perceived symptoms and health-
related quality of life reported by uncomplicated hypertensive patients compared to 
normal controls. Journal of Human Hypertension, 15(8), 539-548. 
https://doi.org/10.1038/sj.jhh.1001236. 
Hagger, M. S., & Orbell, S. (2003). A meta-analytic review of the common-sense model of 
illness representations. Psychology and Health, 18(2), 141-184. 
https://doi.org/10.1080/088704403100081321 
Harris, R. P., Helfand, M., Woolf, S. H., Lohr, K. N., Mulrow, C. D., Teutsch, S. M., ... & Force, 
S. T. (2001). Current methods of the US Preventive Services Task Force: a review of the 
process. American Journal of Preventive Medicine,20(3), 21-35. 
https://doi.org/10.1016/S0749-3797(01)00261-6 
Hayes, D. K., Denny, C. H., Keenan, N. L., Croft, J. B., & Greenlund, K. J. (2008). Health-
related quality of life and hypertension status, awareness, treatment, and control: National 
 19 
 
Health and Nutrition Examination Survey, 2001–2004. Journal of Hypertension, 26(4), 
641-647. https://doi.org/10.1097/HJH.0b013e3282f3eb50 
Jørgensen, P., Langhammer, A., Krokstad, S., & Forsmo, S. (2014). Is there an association 
between disease ignorance and self-rated health? The HUNT Study, a cross-sectional 
survey. BMJ open, 4(5), e004962. http://dx.doi.org/10.1136/bmjopen-2014-004962 
Kaplan, N. M. (1992). The appropriate goals of antihypertensive therapy: Neither too much nor 
too little. Annals of Internal Medicine, 116(8), 686-690. http://doi: 10.7326/0003-4819-
116-8-686 
Lawrence, W. F., Fryback, D. G., Martin, P. A., Klein, R., & Klein, B. E. (1996). Health status 
and hypertension: A population-based study. Journal of Clinical Epidemiology, 49(11), 
1239-1245. https://doi.org/10.1016/S0895-4356(96)00220-X 
Leventhal, H., Leventhal, E. A., & Contrada, R. J. (1998). Self-regulation, health, and behavior: 
A perceptual-cognitive approach. Psychology and Health, 13(4), 717-733. 
https://doi.org/10.1080/08870449808407425 
Martinez, A. G., & Hinshaw, S. P. (2016). Mental health stigma: Theory, developmental issues, 
and research priorities. In D. Cicchetti (Ed.), Developmental psychopathology (pp. 997 – 
1039). Hoboken, NJ: John Wiley & Sons, Inc. doi: 10.1002/9781119125556 
Petersen, S., van den Berg, R. A., Janssens, T., & Van den Bergh, O. (2011). Illness and 
symptom perception: A theoretical approach towards an integrative measurement 
model. Clinical Psychology Review, 31(3), 428-439. 
https://doi.org/10.1016/j.cpr.2010.11.002 
 20 
 
Quinn, D. M., & Earnshaw, V. A. (2011). Understanding concealable stigmatized identities: The 
role of identity in psychological, physical, and behavioral outcomes. Social Issues and 
Policy Review, 5(1), 160-190. 
Report of the National Cholesterol Education Program (NCEP)(3: 2001). (2001). Detection, 
evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).  
Sullivan, P. W., Lawrence, W. F., & Ghushchyan, V. (2005). A national catalog of preference-
based scores for chronic conditions in the United States. Medical Care, 43(7), 736-749. 
https://doi:10.1001/jama.285.19.2486 
Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of 
life: a conceptual model of patient outcomes. Jama, 273(1), 59-65. https:// 
doi:10.1001/jama.1995.03520250075037  
 21 
 
Table 1. Demographics for Three Asymptomatic Diagnostic Conditions 
 
Glucose 
Intolerance 
Hyperlipidemia Hypertension 
Total No. 
Respondents  
6012 2772 5524 
No disease, No. 
(%) 
3805 
(63.3) 
1566 (56.5) 3478 (63.0) 
Unknown 
disease, No. (%) 
1329 
(22.1) 
26 (0.9) 302 (5.5) 
Known disease 
without treatment, No. 
(%) 
322 (5.4) 254 (9.2) 223 (4.0) 
Known disease 
with treatment, No. 
(%) 
556 (9.2) 926 (33.4) 1521 (27.5) 
Age, mean ± SD 
42.5 ± 
20.6 
51.9 ± 17.9 46.3 ± 19.5 
Female, No. (%) 
3023 
(50.2) 
1426 (51.4) 2805 (50.8) 
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Ever smoker, 
No. (%) 
2084 
(34.6) 
1227 (44.2) 2119 (38.3) 
Income     
$0 - $19 999 
1366 
(22.7) 
682 (24.6) 1320 (23.9) 
$20 000 - $44 
999 
1906 
(31.7) 
871 (31.4) 1726 (31.2) 
$45 000 - $99 
999 
1446 
(24.0) 
648 (23.3) 1305 (23.6) 
$100 000 and 
more 
996 
(16.5) 
422 (15.2) 884 (16.0) 
Education, No. 
(%)  
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Less than high 
school 
2063 
(34.3) 
682 (24.6) 1566 (28.3) 
High school 
graduate or GED 
1102 
(18.3) 
592 (21.3) 1107 (20.0) 
Some college or 
associates degree 
1575 
(26.2) 
822 (29.6) 1575 (28.5) 
College graduate 
or above 
1270 
(21.1) 
674 (24.3) 1273 (23.0) 
Race/ ethnicity, 
No. (%) 
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Mexican 
American 
671 
(11.1) 
257 (9.2) 560 (10.1) 
Other Hispanic 631 
(10.5) 
293 (10.5) 560 (10.1) 
Non-Hispanic 
White 
2085 
(34.6) 
1076 (38.8) 1956 (35.4) 
Non-Hispanic 
Black 
1593 
(26.5) 
688 (24.8) 1515 (27.4) 
Non-Hispanic 
Asian 
844 
(14.0) 
389 (14.0) 772 (13.9) 
Other race 
including multi-racial 
188 (3.1) 69 (2.49) 161 (2.9) 
Body mass 
index, mean  ±  SD 
27.8 ± 
7.0 
28.9 ± 6.8 28.3 ± 6.9 
Number of 
comorbidities, mean  ±  
SD 
0.8 ± 1.1 1.1 ± 1.4 0.8 ± 1.2 
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Table 2.Adjusted Odds Ratio Estimates for Responses to the Question, “Would You Say 
Your Health in General is: Excellent, Very Good, Good, Fair, or Poor?” By Disease And 
Diagnostic Group. 
 Glucose Intolerance Hyperlipidemia Hypertension 
Effect 
Point 
Estimate 
95% Wald 
Confidence  
Limits 
Point 
Estimate 
95% Wald 
Confidence  
Limits 
Point 
Estimate 
95% Wald 
Confidence  
Limits 
No 
disease 
0.894 0.772 1.035 1.013 0.468 2.194 0.897 0.701 1.147 
Unknown 
disease  
Reference 
Known 
disease 
without 
treatment 
1.057 0.820 1.362 1.103 0.492 2.472 1.110 0.782 1.575 
Known 
disease 
with 
treatment 
1.065 0.862 1.316 1.053 0.480 2.310 1.119 0.868 1.442 
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a Model adjusted for sex, age, income, body mass index, education, race/ethnicity, and 
number of comorbid conditions. Full model results are available in the Appendix. 
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Table 3. Unadjusted Responses to the Healthy Days Questions by Disease And 
Diagnostic Group 
 
No Diasease 
Unknown 
Disease 
Known Disease 
without tretment 
Known 
Disease  
with 
Treatment 
Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
Hypertension 
Number of days physical 
health was not good 
2.7 ± 6.4 2.9 ± 7.4 6.0 ± 9.9 5.9 ± 9.9 
Number of days mental 
health was not good 
3.8 ± 7.7 2.6 ± 6.4 5.3 ± 8.7 4.2 ± 8.2 
Number of inactive days due 
to physical or mental health 
1.4 ± 4.9 1.2 ± 4.9 3.5 ± 8.0 3.2 ± 7.9 
Hyperlipidemia 
Number of days physical 
health was not good 
3.0 ± 6.8 0.9 ± 2.3 4.6 ± 8.6 6.1 ± 10.1 
Number of days mental 
health was not good 
3.8 ± 7.6 3.5 ± 8.4 5.4 ± 9.5 4.1 ± 8.2 
Number of inactive days due 
to physical or mental health 
1.6 ± 
5.2 
1.0 ± 2.9 2.4 ± 6.7 3.2 ± 7.9 
Glucose Intolerance 
Number of days physical 
health was not good 
2.4 ± 6.0 4.1 ± 8.3 5.7 ± 9.3 6.6 ± 10.5 
Number of days mental 
health was not good 
3.7 ± 7.4 3.6 ± 7.4 5.4 ± 9.3 4.7 ± 8.9 
Number of inactive days due 
to physical or mental health 
1.4 ± 4.6 1.7 ± 5.5 3.8 ± 8.4 3.7 ± 8.6 
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Table 4. Adjusted Multivariate Model Results for the Healthy Day Questions by Disease 
and Diagnostic Group.   
 
No Disease 
Unknown 
Disease 
Known Disease 
without Treatment 
Known 
Disease  
with 
Treatment 
 Estimate (P)  Estimate (P) Estimate (P) 
Hypertension 
Number of days physical health 
was not good 
0.562 (0.29) 
ref 
2.453 (0.001) 1.102 (0.041) 
Number of days mental health 
was not good 
0.676 (0.20) 
ref 
1.905 (0.010) 0.702 (0.19) 
Number of inactive days due to 
physical or mental health 
0.571 (0.16) 
ref 
1.816 (0.001) 1.0432 (0.012) 
Hyperlipidemia 
Number of days physical health 
was not good 
1.595 (0.34) ref 2.445 (0.1653) 2.760 (0.11) 
Number of days mental health 
was not good 
-0.391 (0.81) ref  1.235 (0.4776) -0.085 (0.96) 
Number of inactive days due to 
physical or mental health 
0.332 (0.80) ref  0.705 (0.6010) 0.727 (0.58) 
Glucose Intolerance 
Number of days physical health 
was not good 
-0.789 (0.010) ref 0.329 (0.53) 0.443 (0.31) 
Number of days mental health 
was not good 
0.069 (0.83) ref 0.989 (0.07) 0.666 (0.14) 
Number of inactive days due to 
physical or mental health 
0.267 (0.25) ref 1.424 (0.0003) 0.852 (0.010) 
 
a Model adjusted for sex, age, income, body mass index, education, race/ethnicity, and 
number of comorbid conditions.  Full model results are available in the Appendix. 
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Figure 1: Unadjusted responses to the question, “Would you say your health in general 
is: excellent, very good, good, fair, or poor?” by disease and diagnostic group. 
 
